drugset / Trial / NCT03892564

Evaluation of Potential Phototoxicity Skin Reaction After Use of MC2-01 Cream

NCT03892564

Phase 1 Completed 35 enrolled MC2 Therapeutics
RandomizedParallel-groupDouble-blindTreatment

Summary

This trial is a 4-day, randomized study to determine the phototoxic potential of MC2-01 Cream when topical application to healthy skin is followed by light exposure.

Timeline

Start
2019-02-27
Primary completion
2019-03-09
Completion
2019-03-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Calcipotriol Small molecule 0.005 % Topical
Subject betamethasone dipropionate Small molecule 0.064 % Topical

Indications